Triumph Capital Management Has $278,000 Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Triumph Capital Management decreased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 17.5% in the fourth quarter, HoldingsChannel reports. The firm owned 527 shares of the healthcare conglomerate’s stock after selling 112 shares during the period. Triumph Capital Management’s holdings in UnitedHealth Group were worth $278,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in UNH. Robbins Farley purchased a new stake in UnitedHealth Group in the 3rd quarter worth approximately $25,000. Richelieu Gestion SA bought a new position in shares of UnitedHealth Group during the 4th quarter valued at $26,000. CGC Financial Services LLC raised its holdings in shares of UnitedHealth Group by 1,000.0% during the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after purchasing an additional 50 shares in the last quarter. NewSquare Capital LLC raised its holdings in shares of UnitedHealth Group by 340.0% during the 3rd quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock valued at $33,000 after purchasing an additional 51 shares in the last quarter. Finally, LFA Lugano Financial Advisors SA raised its holdings in shares of UnitedHealth Group by 148.1% during the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock valued at $35,000 after purchasing an additional 40 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analysts Set New Price Targets

Several research analysts recently commented on the stock. Erste Group Bank reiterated a “hold” rating on shares of UnitedHealth Group in a report on Wednesday, March 13th. Piper Sandler lifted their target price on shares of UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a report on Wednesday, April 17th. HSBC upgraded shares of UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 target price on the stock in a report on Thursday, April 4th. Royal Bank of Canada decreased their price target on shares of UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 17th. Finally, Oppenheimer restated an “outperform” rating and issued a $610.00 price target on shares of UnitedHealth Group in a research report on Wednesday, January 17th. Four research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat, UnitedHealth Group has a consensus rating of “Moderate Buy” and a consensus price target of $570.05.

UnitedHealth Group Trading Up 0.1 %

Shares of UNH stock opened at $484.11 on Thursday. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $554.70. The company has a market capitalization of $445.42 billion, a P/E ratio of 29.59, a P/E/G ratio of 1.40 and a beta of 0.55. The firm has a 50-day moving average price of $483.69 and a 200 day moving average price of $513.21. The company has a quick ratio of 0.79, a current ratio of 0.85 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The firm had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. During the same period last year, the firm posted $6.26 EPS. The firm’s quarterly revenue was up 8.6% on a year-over-year basis. Research analysts forecast that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were paid a $1.88 dividend. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.55%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s dividend payout ratio is presently 45.97%.

Insiders Place Their Bets

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. In related news, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.